Maximizing Outcomes in Treating Acute Migraine

NCT03896009 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1594

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: AXS-07 (MoSEIC meloxicam and rizatriptan)
DRUG: Meloxicam
DRUG: Rizatriptan
DRUG: Placebo

Sponsor

Axsome Therapeutics, Inc.